Ask the Expert: What Are Some of the Challenges for Urologists Treating Metastatic Castrate Resistant Prostate Cancer Patients?

Posted by Lawrence I. Karsh, MD | Nov 2017

Lawrence Karsh, MD, The Urology Center of Colorado, Denver, Colorado, discusses what some of the challenges are for urologists treating metastatic castrate resistant prostate cancer patients.

Interview produced by Prostatepedia

Keywords: metastatic castrate resistant prostate cancer, learning curve, adverse events, therapies, clinical practice

About The Author

Lawrence I. Karsh, MD

Lawrence I. Karsh, MD, is a Co-Founder of The Urology Center of Colorado, where he serves as an attending urologist and Director of Research & Co-Chairman of the Advanced Therapeutic Clinic. He is a certified principal investigator, and has been the principal investigator on over 250 clinical trials. He has authored a number of peer-reviewed publications and serves on the editorial boards for Oncology Live, Urologists in Cancer Care, and Bladder Cancer. He is a fellow of the American College of Surgeons, and an active member of the AUA, SUO, ASCO, SWOG, ACS, and the Denver Academy of Surgeons. He has served on the bladder cancer subcommittee and the advisory board for the SUO Clinical Trials Consortium and is a member of the Bladder Cancer Advocacy Network (BCAN) Think Tank. Dr. Karsh completed his general surgery training at the University of Colorado Health Sciences Center (UCHSC) and his urology residency at Brigham and Women’s Hospital/Harvard Medical School. He is an Associate Clinical Professor of Surgery at UCHSC. Dr. Karsh participates in many advisory boards for new drug development. He lectures and teaches at scientific meetings throughout the country.

Join the GRU Community

- Why Join? -

Share This

Chat with usLiveChat